GOVX
GeoVax Labs, Inc.Company with tickers: GOVX
CIK
832489
CUSIP
373678705
Shares Outstanding
5,210,465
13F Activity (30d)
14 filings
14 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $5,272,881 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $3,903,463 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-5,272,881 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-5,261,921 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-2.62 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | — |